CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC was delisted on the 23rd of June, 2023.
98 hedge funds and large institutions have $110M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 15 closing their positions.
363% more call options, than puts
Call options by funds: $3.17M | Put options by funds: $683K
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
9% more funds holding
Funds holding: 90 → 98 (+8)
25% less capital invested
Capital invested by funds: $148M → $110M (-$37M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.7M |
| 3 |
Millennium Management
New York
|
+$10.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$18.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.35M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.9M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$3.36M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.9M |
CTIC Hedge Fund Activity: Q1 2015 in Review
98 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q1 2015, worth a combined $110M — down 25% from $148M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new CTIC positions and 15 closed out — a net gain of 8 holders — while 36 added to existing stakes and 17 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11M. The largest seller was Eagle Asset Management, cutting an estimated $18.9M.
- 98 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q1 2015, up from 90 in Q4 2014.
- Funds reported $110M of CTI BioPharma Corp. (DE) Common Stock stock for Q1 2015, down 25% quarter-over-quarter.
- 23 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q1 2015 and 15 closed out, a net change of +8 holders.
- The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q1 2015 was Fidelity Investments, an estimated $11M added.
- The largest CTI BioPharma Corp. (DE) Common Stock seller in Q1 2015 was Eagle Asset Management, an estimated $18.9M sold.
Based on aggregated 13F filings for Q1 2015.